What is Stokes Pharmacy?
Established in 1975, Stokes Pharmacy is dedicated to enhancing patient outcomes through specialized compounded medications for both human and veterinary applications. The company offers a diverse portfolio, including treatments for conditions like feline infectious peritonitis (FIP) and various equine medications. Serving a broad clientele that encompasses pet owners, veterinary clinics, and human patients, Stokes Pharmacy has built a reputation for its unwavering commitment to quality, safety, and the efficacy of its preparations. Their operational model emphasizes fast delivery and superior customer service, all while adhering to stringent quality standards to meet the high expectations of both patients and veterinary professionals.
How much funding has Stokes Pharmacy raised?
Stokes Pharmacy has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Stokes Pharmacy
PPP
Public-Private Partnership
What's next for Stokes Pharmacy?
The substantial enterprise-level funding and recent strategic investment position Stokes Pharmacy for accelerated expansion and innovation. This capital injection is likely to fuel advancements in their compounding technologies, broaden their product lines, and potentially enhance their market reach within both the human and veterinary pharmaceutical sectors. The company's focus on quality and patient outcomes, combined with its established history, suggests a trajectory aimed at solidifying its leadership in specialized pharmaceutical compounding and exploring new avenues for growth and service enhancement.
See full Stokes Pharmacy company page
